Business Description
InnoCare Pharma is a Beijing-based drug company founded in 2015 that focuses on developing treatments for cancer and autoimmune diseases in China. Its most advanced drug, Orelabrutinib, targets a protein called BTK and is used to treat several blood cancers as well as conditions like lupus, multiple sclerosis, and other immune disorders. The company also has a broad pipeline of other drugs in development aimed at additional cancer types and immune-related diseases.
